83
Participants
Start Date
December 12, 2018
Primary Completion Date
November 23, 2020
Study Completion Date
November 23, 2020
DAXI for injection 250 U
DaxibotulinumtoxinA for injection is a sterile, white to off-white lyophilized product containing the active ingredient, daxibotulinumtoxinA, and inactive ingredients to be reconstituted with sterile, non-preserved, 0.9% sodium chloride solution saline
DAXI for injection 375 U
DaxibotulinumtoxinA for injection is a sterile, white to off-white lyophilized product containing the active ingredient, daxibotulinumtoxinA, and inactive ingredients to be reconstituted with sterile, non-preserved, 0.9% sodium chloride solution saline.
DAXI for injection 500 U
DaxibotulinumtoxinA for injection is a sterile, white to off-white lyophilized product containing the active ingredient, daxibotulinumtoxinA, and inactive ingredients to be reconstituted with sterile, non-preserved, 0.9% sodium chloride solution saline
Placebo
Placebo is a sterile lyophilized product consisting of inactive ingredients without the neurotoxin to be reconstituted with sterile, non-preserved 0.9% sodium chloride solution.
Icahn School of Medicine at Mount Sinai, New York
University of Pittsburgh School of Medicine, Pittsburgh
MedStar National Rehabilitation Hospital, Washington D.C.
Wake Forest University School of Medicine, Salem
Carolinas Rehabilitation, Charlotte
Infinity Clinical Research, Hollywood
Parkinsons Disease and Movement Disorders Center, Boca Raton
Vanderbilt University Medical Center, Nashville
William Beaumont Hospital, Royal Oak
Rusk Rehabilitation Hospital, Columbia
North Texas Institute of Neurology and Headache, Frisco
University of Texas Health Science Center at Houston, Houston
University of Utah, Salt Lake City
Rancho Research Institute at Rancho Los Amigos National Rehab Center, Downey
Collaborative Neuroscience Network LLC, Long Beach
SC3 Research, Pasadena
The Parkinsons and Movement Disorder Institute, Fountain Valley
Yale University, Fairfield
Waterbury Neurologists, Middlebury
Ki Health Partners LLC DBA New England Institute for Clinical Research, Stamford
NW FL Clinical Research Group, LLC, Gulf Breeze
Parkinsons Disease Treatment Center of Southwest Florida, Port Charlotte
Shirley Ryan AbilityLab, Chicago
Kansas Institute of Research, Overland Park
Weill Cornell Medical College, New York
MossRehab, Elkins Park
Revance Therapeutics, Inc.
INDUSTRY